STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer after transplant? drug trial shows promise
Disease control TerminatedThis study tested the drug lenvatinib in people whose liver cancer returned after a liver transplant. The goal was to see if the drug could shrink or slow the cancer. Only 3 people took part before the study was stopped early, so results are very limited.
Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Liver cancer drug combo shows promise but study halted early
Disease control TerminatedThis study tested whether two immunotherapy drugs, nivolumab and ipilimumab, could shrink tumors in people with advanced liver cancer that had already been treated with another drug combination. The trial enrolled 15 adults whose cancer had spread or could not be removed by surge…
Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC